11:15 AM EDT, 10/31/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were falling significantly lower late Thursday morning, dropping 1.4% to 1,347.70 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and semiconductor company Sequans Communications ( SQNS ) , which rose 3.8% and 2.6% respectively. They were followed by financial services company Banco Santander (SAN) and internet advertising firm Criteo ( CRTO ) , which were up 2.1% and 2% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and brewing company Anheuser-Busch InBev ( BUD ) , which lost 12% and 5.8% respectively. They were followed by 3D printer company Materialise (MTLS) and petroleum refiner Equinor ( EQNR ) , which dropped 3.1% and 2.7% respectively.

From the UK and Ireland, the gainers were led by oil and gas company Shell (SHEL) and Adaptimmune Therapeutics ( ADAP ) , which increased 1.7% and 0.9% respectively. They were followed by tobacco company British American Tobacco ( BTI ) and cruise line operator Carnival (CUK), which advanced 0.8% and 0.6% respectively.

The decliners from the UK and Ireland were led by medical device maker Smith & Nephew ( SNN ) and biopharmaceutical company TC Biopharm ( TCBP ) , which tumbled 13.3% and 6.8% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Amarin ( AMRN ) , which fell 4% and 2.6% respectively.